General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cheetham TC et al. – In general, nonselective NSAIDs and selective COX–2 inhibitors should be avoided in patients taking warfarin. In situations where patients require NSAIDs and cannot be managed using other therapies, The results suggest that selective COX–2 inhibitors are associated with fewer hospitalizations for GI bleeding.

Related Articles

Safety of Concomitant Tamoxifen and Warfarin
Annals of Pharmacotherapy, 10/21/09    Relevance Score: 90%

Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation
Cerebrovascular Diseases, 11/12/09    Relevance Score: 89%

Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients
Clinical Medicine & Research, 10/09/09    Relevance Score: 87%

Can We Predict Daily Adherence to Warfarin? Results from the IN-RANGE Study
Chest, 11/12/09    Relevance Score: 85%

Uninterrupted Warfarin for Periprocedural Anticoagulation in Catheter Ablation of Typical Atrial Flutter: A Safe and Cost-Effective Strategy
Journal of Cardiovascular Electrophysiology, 10/06/09    Relevance Score: 85%

Today in Pharmacology/kinetics...keeping you current

Effects of Ecabet Sodium on Acute Mixed Reflux Esophagitis
Scandinavian Journal of Gastroenterology, 12/06/09

Gastric infection by Helicobacter pylori
Current Gastroenterology Reports, 12/06/09

Is stomach spontaneously ageing? Pathophysiology of the ageing stomach
Best Practice & Research Clinical Gastroenterology , 12/06/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address